UBS Group’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-59,864
| Closed | -$12K | – | 7426 |
|
|
2019
Q3 | $12K | Sell |
59,864
-4,620
| -7% | -$926 | ﹤0.01% | 6118 |
|
|
2019
Q2 | $56K | Buy |
64,484
+32,386
| +101% | +$28.1K | ﹤0.01% | 4973 |
|
|
2019
Q1 | $75K | Buy |
32,098
+23,042
| +254% | +$53.8K | ﹤0.01% | 4483 |
|
|
2018
Q4 | $21K | Buy |
9,056
+4,170
| +85% | +$9.67K | ﹤0.01% | 5853 |
|
|
2018
Q3 | $72K | Buy |
4,886
+586
| +14% | +$8.64K | ﹤0.01% | 4986 |
|
|
2018
Q2 | $65K | Buy |
4,300
+1,061
| +33% | +$16K | ﹤0.01% | 4903 |
|
|
2018
Q1 | $61K | Buy |
3,239
+266
| +9% | +$5.01K | ﹤0.01% | 4728 |
|
|
2017
Q4 | $54K | Buy |
2,973
+485
| +19% | +$8.81K | ﹤0.01% | 4847 |
|
|
2017
Q3 | $55K | Buy |
+2,488
| New | +$55K | ﹤0.01% | 4852 |
|